Log in
Enquire now
‌

US Patent 7807780 Multi-component biological transport systems

Patent 7807780 was granted and assigned to Revance Therapeutics, Inc. on October, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Current Assignee
‌
Revance Therapeutics, Inc.
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
78077801
Patent Inventor Names
Jacob Waugh1
Michael Dake1
Date of Patent
October 5, 2010
1
Patent Application Number
099104321
Date Filed
July 20, 2001
1
Patent Citations Received
‌
US Patent 11911449 Albumin-free botulinum toxin formulations
2
Patent Primary Examiner
‌
Richard Schnizer
1
Patent abstract

Compositions and methods are provided that are useful for the delivery of therapeutic agents, including nucleic acids. The compositions can be prepared with components useful for targeting the delivery of the compositions as well as imaging components.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7807780 Multi-component biological transport systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.